Pilot Study Evaluating the Safety and Performance of the GeNO Nitrosyl Delivery System for Inhaled Nitric Oxide



Status:Archived
Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:October 2010
End Date:February 2011

Use our guide to learn which trials are right for you!

An Open Label Pilot Study Evaluating Preliminary Safety and Performance of the GeNO Nitrosyl Delivery System


This is an open label phase 2 Pilot study designed to evaluate the safety, tolerability and
device performance of the GeNO nitrosyl delivery system during right heart catheterization
(RHC) in participants with pulmonary arterial hypertension (PAH). All participants will
receive inhaled nitric oxide in oxygen or nitric oxide in air delivered by nasal cannula.
Hemodynamics, clinical laboratory and clinical assessment data will be collected on all
participants to evaluate safety.



We found this trial at
1
site
Boston, Massachusetts 02111
?
mi
from
Boston, MA
Click here to add this to my saved trials